A pilot study to evaluate the safety and tolerability of RepaiRx in donor site healing

Phase 2

• Conditions: Wound healing; Skin - Other skin conditions; Injuries and Accidents - Burns

• Registration Number: ACTRN12615000717550
• Lead Sponsor: VARNZ Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-07-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Males and females aged at least 18 years requiring split thickness skin grafts for reasons of burn therapy, trauma or scar revision. The area requiring skin grafting is to be greater than or equal to 1% and no more than 20% of the total body surface area.

Exclusion Criteria

Pre-existing infection or condition or taking medication that may interfere with wound healing; airway burn; renal failure requiring dialysis; participation in other clinical trial/s; known allergy to deer products, poloxamer gel or mepitel film;history of skin disorders

Study & Design

• Study Type: Interventional
• Study Design: Not specified